Skip to main content

Advertisement

SpringerLink
Log in

Acetylcholinesterase assay may predict cognitive response of Alzheimer patients to eptastigmine treatment

  • LETTER TO THE EDITORS
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Medical Department, Mediolanum Farmaceutici, Via Cottolengo 15, I-20143 Milan, Italy Tel.: +39 2 89132348; Fax: +39 2 89132375, , , , , , IT

    B. P. Imbimbo, P. Martelli & G. P. Ferrari

  2. Azienda Ospedaliere, Verona, Italy, , , , , , IT

    M. Nicoli

  3. Azienda Ospedaliere, Verona, Italy, , , , , , IT

    C. Martini, G. P. Tomelleri & G. Gambina

Authors
  1. B. P. Imbimbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Nicoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Martini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. P. Tomelleri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Martelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. P. Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Gambina
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 28 April 1998 / Accepted in revised form: 12 August 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Imbimbo, B., Nicoli, M., Martini, C. et al. Acetylcholinesterase assay may predict cognitive response of Alzheimer patients to eptastigmine treatment. E J Clin Pharmacol 54, 809–810 (1998). https://doi.org/10.1007/s002280050556

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002280050556

Search

Navigation